Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D2KA0W
|
|||
| Drug Name |
GS-2872
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Human immunodeficiency virus infection [ICD-11: 1C62] | Phase 1 | [1] | |
| Company |
Gilead Sciences
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04811040) Study to Evaluate the Safety and Efficacy of GS-5423 and GS-2872 in Combination With Lenacapavir (GS-6207) in Virologically Suppressed Adults With HIV-1 Infection. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.